During the evaluation of this active substance, a number of concerns have been identified. In particular it was not possible to perform a reliable consumer exposure assessment as data are missing to determine an appropriate residue definition. Consequently, it was not possible to conclude on the basis of the information available that buprofezin met the criteria for inclusion in Annex I to Directive 91/414/EEC.
Recital 5, Decision_act (EU) 2008/771
In force
- celex=31991L0414